Skip to content
Tenfell
Awarded contract
Published 16 Jul 2020

Generic Drugs — Oral Liquids

Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales Health Boards and Trusts) · United Kingdom

Key facts

Contract value
€4,278,360
Awarded
30 Jun 2020
Contract starts
01 Jul 2020
Contract ends
30 Jun 2023
Procedure
Open procedure
Buyer type
Health

Awarded to 26 suppliers

SupplierValue
Crescent Pharma Limited€543,961
Dr Falk Pharma UK Ltd€15,433
Drugsrus Ltd€176,854
FLYNN PHARMA LTD€11,904
Focus Pharmaceuticals Ltd€93,237
Glaxo Smithkline€109,858
Intrapharm Laboratories Ltd€15,679
Kent Pharmaceuticals Ltd€140,551
LogixX Pharma Ltd€1,921
Martindale€277,462
Medreich PLC€51,819
Mercury Pharmaceuticals Limited€285,108
Novartis Pharmaceuticals UK Ltd€83,179
Pfizer Ltd€261,576
Qdem Pharmaceuticals€5,113
Reckitt Benckiser Healthcare (UK) Ltd€133,752
Roche Products Ltd€86,593
Rosemont Pharmaceuticals Ltd€792,792
Sandoz Ltd€264,757
Sanofi€88,451
Selective Supplies Ltd€30,671
Teva UK Ltd€249,674
Thornton & Ross Ltd€93,195
Typharm Ltd€76,153
UPJOHN UK LIMITED€26,448
Wockhardt UK Limited€362,218

Categories (CPV)

Similar open tenders

About Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales Health Boards and Trusts)

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on TED archive (UK notices before Brexit) (EU open data (Decision 2011/833/EU)). Always read the original notice before responding.